Clinical Trials in Miami

Showing 3101-3120 of 11,431 trials

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

NCT05563272

A prospective, open-label, phase 2 study to explore CAIX expression through 89Zirconium-labelled girentuximab deferoxamine (89Zr-girentuximab) PET/CT imaging in patients with solid tumors.

Cervical CancerColorectal CancerEsophageal Cancer+16 more

Telix Pharmaceuticals (Innovations) Pty Ltd11 participantsStarted Jun 2023

Los Angeles, California, United States • Miami, Florida, United States • Boston, Massachusetts, United States +7 more locations

COMPLETEDPhase 2< 1 mile

A Study in Participants With Non-cirrhotic NASH With Fibrosis

NCT05638737

This is a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial. Participants will be in the trial for up to 24 weeks, including a screening period lasting up to 8 weeks, a 12-week treatment period, and a 4-week safety follow-up period Participants are not expected to directly benefit from treatment during this trial. Participants will help researchers learn more about and how to develop AZD4831 to treat NASH.

Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

AstraZeneca112 participantsStarted Oct 2022

Chandler, Arizona, United States • Tucson, Arizona, United States • Chula Vista, California, United States +62 more locations

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Find Trials by Condition in Miami

RNS System NAUTILUS Study

A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subjects With Hypertension and Chronic Kidney Disease (CKD) With Albuminuria

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

GWICTIC: NAC Mechanistic Study in Gulf War Veterans

A Ph2b to Evaluate Clinical Efficacy and Safety of Tildacerfont in Adult CAH

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis

STRIDE Study - A Study in Subjects With LOPD Who Are Currently Being Treated With ERT

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma